April 10, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Jeffrey P. Riedler | |
Alla Berenshteyn |
Re: | XBiotech Inc. |
Registration Statement on Form S-1, as amended
File No. 333-201813
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the Securities Act), the undersigned, W.R. Hambrecht + Co., LLC, as the underwriter of the offering pursuant to the above-referenced Registration Statement on Form S-1, as amended (the Registration Statement), hereby joins in the request of XBiotech Inc. that the effective date of the Registration Statement be accelerated so that the Registration Statement becomes effective at 1:00 p.m. (Eastern time) on April 14, 2015 or as soon thereafter as practicable.
In connection with this acceleration request and pursuant to Rule 460 under the Securities Act, the following information is provided with respect to the distribution of the preliminary prospectus included in the Registration Statement during the period of March 27, 2015 to April 10, 2015:
To Whom Distributed
Prospective underwriters, dealers, institutional investors and others
Number of copies
850
In connection with the preliminary prospectus distribution, we are complying with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours, | ||
W.R. Hambrecht + Co., LLC | ||
By: | W.R. Hambrecht + Co., LLC | |
By | /s/ Whitney White | |
Authorized Officer |